(Bloomberg) -- Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s...
-- Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide.“We recognize the significant interest in obesity,” Amgen CEO Robert Bradway said Thursday on a call with investors. “We are confident in MariTide’s differentiated profile and believe it will address important unmet medical needs.” Amgen shares rose more than 13% in trading before US markets opened on Friday.
The company will focus on MariTide and discontinue development of another, earlier-stage drug called AMG 786, Jay Bradner, Amgen’s R&D chief, said on the call.Will GM Regret Kicking Apple CarPlay off the Dashboard?ECB Isn’t Pre-Committing to Particular Rate Path, Lane Says VANCOUVER — Retailer London Drugs says it's rebuilding its data infrastructure with the help of leading third-party experts to bring its operations safely back online after a cybersecurity incident that has shut down stores for five days. The store says in a statement that there are billions of lines of data and code to review, but its teams have been working around the clock and there is progress. The Richmond, B.C.,-based company has more than 80 stores across B.C.
Amgen Amgen CEO Chief Executive Officer Robert Bradway
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Amgen Soars After CEO Gives Update on Experimental Obesity DrugAmgen Inc.’s shares soared in late trading after its chief executive officer said he was “very encouraged” by early results from a study of the company’s experimental obesity drug, MariTide.
Read more »
JPMorgan CEO Jamie Dimon Gives a Soft Landing Long OddsJamie Dimon says the U.S. consumer is in good shape right now, but a huge fiscal deficit and geopolitical challenges make him cautious about the future. The ...
Read more »
Amgen, DraftKings, Live Nation: Trending tickersShares of Amgen (AMGN) are soaring at Thursday's market close after reporting first quarter results, with revenue exceeding expectations. The biotechnology...
Read more »
Amgen investors await weight-loss drug dataExplore stories from Atlantic Canada.
Read more »
Carvana Short-Seller Losses Hit $3.9 Billion as Stock SoarsCarvana Co.’s surge Thursday added to pain for short sellers who’ve amassed major losses betting against the used car retailer as its shares have rebounded over the last year.
Read more »
Woman Born Without Arms Soars The Skies Using Her Feet As First Fully Licensed PilotBorn without arms, this woman proved her doubters wrong by becoming the first licensed pilot to fly plane with just her feet.
Read more »